FemTech market reaches $360 billion potential. Yet funding remains at 8.5% of digital health investment.
The gap is opportunity. Menopause solutions scale rapidly. Mental health meets hormonal health. B2B employer benefits drive adoption. Clinical validation replaces wellness claims.
This guide lists 40+ active femtech investors in 2025. Focus areas. Check sizes. Direct contacts.
Track your femtech pitch deck
Clinical trials show clear outcomes. Pilot programs convert. B2B employers sign contracts.
But investors still hesitate.
Static PDFs disappear in inboxes. No visibility into engagement. Can't track internal sharing.
Ellty provides real pitch deck analytics. See exactly who views what.
Top 40 femtech investors
1. FemHealth Ventures
Dedicated women's health venture capital firm.
Investment focus: Conditions affecting only women, mostly women, or worse in women
Investment range: Seed to Series A, $500K-$5M
Notable investments: Women's health across the spectrum
Contact: femhealthventures.com
2. Amboy Street Ventures
World's first VC focused on sexual health and women's health tech.
Investment focus: Sexual wellness, reproductive health, pelvic health
Investment range: Seed to Series A
Notable investments: Sexual and reproductive health companies
Contact: amboystreetventures.com
3. Goddess Gaia Ventures
$1.1 trillion women's healthcare market specialist.
Investment focus: Fertility, women's cancers, wellness, lifestyle diseases
Investment range: Early stage
Notable investments: Five core women's health pillars
Contact: goddessgaiaventures.com
4. Rethink Impact
Leading gender lens investor with femtech portfolio.
Investment focus: Women's health tech transforming healthcare
Investment range: Series A-B, $3M-$15M
Notable investments: Female-founded health companies
Contact: rethinkimpact.com
5. DEPO Ventures
CEE-focused investor with femtech dedication.
Investment focus: Women's health and wellness innovation
Investment range: Pre-seed to Series A
Notable investments: European femtech startups
Contact: depoventures.com
6. Flow Capital
Growth capital provider for femtech scale-ups.
Investment focus: Female-focused healthcare innovation
Investment range: Series A+, debt and equity
Notable investments: Revenue-generating femtech companies
Contact: flowcap.com
7. Groove Capital
Innovation-focused femtech investor.
Investment focus: Women's health technology disruption
Investment range: Seed to Series A
Notable investments: Femtech platforms and services
Contact: groovecapital.com
8. Render Capital
Supporting underrepresented founders in femtech.
Investment focus: Women's health accessibility and innovation
Investment range: Pre-seed to seed, $100K-$1M
Notable investments: Diverse femtech founders
Contact: render.capital
9. The Venture Collective (TVC)
Community-driven femtech investor.
Investment focus: Innovative women's health solutions
Investment range: Pre-seed to Series A
Notable investments: Women-led health companies
Contact: theventurecollective.com
10. Portfolia
Women investors funding women's health.
Investment focus: FemTech Fund dedicated to women's health
Investment range: Seed to Series B
Notable investments: 20+ femtech companies
Contact: portfolia.com
11. Enterprise Ireland
Irish government supporting femtech innovation.
Investment focus: Irish and Irish-connected femtech startups
Investment range: €50K-€1M
Notable investments: European femtech companies
Contact: enterprise-ireland.com
12. Slow Ventures
Early-stage generalist with femtech interest.
Investment focus: Consumer health, women's wellness
Investment range: Seed to Series A
Notable investments: Multiple femtech platforms
Contact: slow.co
13. Perceptive Advisors
Healthcare specialist with femtech portfolio.
Investment focus: Women's health therapeutics and diagnostics
Investment range: Series B+, $10M-$100M
Notable investments: Clinical-stage femtech
Contact: perceptivelife.com
14. Khosla Ventures
Deep tech investor backing femtech innovation.
Investment focus: Breakthrough women's health technology
Investment range: Seed to growth
Notable investments: Technology-first femtech
Contact: khoslaventures.com
15. Y Combinator
Leading accelerator with growing femtech portfolio.
Investment focus: All aspects of women's health tech
Investment range: $500K for 7%
Notable investments: Maven, Modern Fertility, others
Contact: ycombinator.com
16. Union Square Ventures
NYC firm investing in femtech networks.
Investment focus: Women's health platforms and communities
Investment range: Seed to Series B
Notable investments: Network-effect femtech companies
Contact: usv.com
17. Bessemer Venture Partners
Century-old firm with femtech practice.
Investment focus: Digital women's health, B2B femtech
Investment range: Series A to growth
Notable investments: Enterprise femtech solutions
Contact: bvp.com
18. Maveron
Consumer-focused VC backing femtech brands.
Investment focus: Consumer women's health brands
Investment range: Seed to Series B
Notable investments: D2C femtech companies
Contact: maveron.com
19. GV (Google Ventures)
Alphabet's venture arm investing in femtech.
Investment focus: Technology-enabled women's health
Investment range: Seed to growth
Notable investments: Digital health platforms
Contact: gv.com
20. Forerunner Ventures
Consumer VC with femtech investments.
Investment focus: Women's wellness brands
Investment range: Seed to Series B
Notable investments: Consumer femtech products
Contact: forerunnerventures.com
21. BBG Ventures
Women-founded companies specialist.
Investment focus: Female founders in health
Investment range: Seed, $100K-$500K
Notable investments: Women's health startups
Contact: bbgventures.com
22. Female Founders Fund
Investing in female-founded companies.
Investment focus: Women's health and wellness
Investment range: Pre-seed to Series A
Notable investments: Female-led femtech
Contact: femalefoundersfund.com
23. Canaan Partners
Healthcare investor with femtech focus.
Investment focus: Women's health innovation
Investment range: Series A to growth
Notable investments: Clinical femtech companies
Contact: canaan.com
24. Rock Health
Digital health fund including femtech.
Investment focus: Digital women's health solutions
Investment range: Seed to Series A
Notable investments: Digital health platforms
Contact: rockhealth.com
25. SOSV
Global accelerator VC with femtech track.
Investment focus: Deep tech femtech solutions
Investment range: Pre-seed, $150K-$250K
Notable investments: IndieBio femtech alumni
Contact: sosv.com
26. Johnson & Johnson Innovation
Corporate venture arm investing in femtech.
Investment focus: Women's health medical devices and digital
Investment range: Strategic investments
Notable investments: Clinical-stage femtech
Contact: jnjinnovation.com
27. NEA (New Enterprise Associates)
Large fund with women's health practice.
Investment focus: Transformative women's health
Investment range: Seed to growth
Notable investments: Multiple femtech unicorns
Contact: nea.com
28. Accel
Global VC with femtech investments.
Investment focus: European and US femtech
Investment range: Seed to growth
Notable investments: Technology platforms
Contact: accel.com
29. Foundry Group
Boulder-based VC backing femtech.
Investment focus: Technology-driven women's health
Investment range: Seed to Series B
Notable investments: B2B femtech platforms
Contact: foundrygroup.com
30. OrbiMed
Healthcare specialist with femtech portfolio.
Investment focus: Clinical-stage women's health
Investment range: Series B+, $10M-$100M
Notable investments: Therapeutics and diagnostics
Contact: orbimed.com
31. Hambro Perks
UK investor with femtech focus.
Investment focus: European women's health innovation
Investment range: Pre-seed to Series D
Notable investments: UK femtech leaders
Contact: hambroperks.com
32. Atlantic Labs
Berlin-based early-stage investor.
Investment focus: European femtech startups
Investment range: Pre-seed to seed
Notable investments: DACH region femtech
Contact: atlanticlabs.de
33. Storm Ventures
Enterprise-focused with B2B femtech interest.
Investment focus: B2B women's health solutions
Investment range: Series A-B
Notable investments: Enterprise femtech
Contact: stormventures.com
34. Octopus Ventures
UK/Europe investor with femtech portfolio.
Investment focus: Scalable women's health tech
Investment range: Series A to growth
Notable investments: European femtech leaders
Contact: octopusventures.com
35. Lux Capital
Science-focused investor in femtech.
Investment focus: Breakthrough women's health science
Investment range: Seed to growth
Notable investments: Deep tech femtech
Contact: luxcapital.com
36. Obvious Ventures
Impact investor with femtech focus.
Investment focus: Sustainable women's health
Investment range: Seed to Series B
Notable investments: Mission-driven femtech
Contact: obvious.com
37. Astia
Women-focused investor network.
Investment focus: High-growth women's ventures
Investment range: Angel to Series A
Notable investments: Women-led companies
Contact: astia.org
38. Coyote Ventures
Seed fund with femtech investments.
Investment focus: Women's digital health
Investment range: Pre-seed to seed
Notable investments: Early femtech startups
Contact: coyote.vc
39. Homebrew
Seed VC backing femtech founders.
Investment focus: Bottom-up innovation in health
Investment range: Seed, $500K-$2M
Notable investments: Mission-driven teams
Contact: homebrew.co
40. M13
LA-based investor with femtech portfolio.
Investment focus: Consumer women's health brands
Investment range: Seed to Series B
Notable investments: D2C femtech companies
Contact: m13.co
Pitching femtech investors
The data gap advantage
Women's health is 50% of the population but <5% of research. Every pitch starts here.
Market size: Not just women 15-45. Include menopause ($600B), PCOS (10% of women), endometriosis (1 in 10).
Clinical evidence: Real outcomes data. Not wellness claims. FDA pathway if applicable.
B2B potential: Employers care about women's health ROI. Show productivity gains.
What gets funded
Beyond fertility: Menopause, cardiovascular, autoimmune, mental health
Clinical validation: Peer-reviewed studies or clinical trials
Diverse founding team: Clinical advisors essential
Clear reimbursement path: CPT codes or employer benefits
Common mistakes
Narrow market definition. Women's health isn't niche.
Pink it and shrink it. Not just making existing solutions pink.
Ignoring B2B. Employers and payers drive scale.
Alternative funding sources
Corporate venture
Bayer G4A: Women's health focus area
P&G Ventures: Feminine care innovation
Roche Ventures: Diagnostics and digital health
Merck for Mothers: Maternal health focus
Government grants
NIH Office of Women's Health: $50M+ annually
SBIR/STTR: Femtech-specific topics
EU Gender Innovations: €100M+ for women's health
Wellcome Trust: Global women's health
Accelerators
Techstars + Cedars-Sinai: Women's health track
MassChallenge HealthTech: Femtech cohort
Village Capital: Women's health programs
Anthill Ventures: Female founder focus
Success stories
Recent mega-rounds
Kindbody: $100M+ for fertility clinics. B2B employer benefits model.
Maven Clinic: $110M Series D. Virtual women's health platform.
Tia: $100M Series B. Whole woman healthcare model.
Emerging winners
Midi Health: $25M for menopause care. Telehealth plus insurance coverage.
Allara: PCOS-focused platform. Subscription model working.
Evernow: Menopause symptom relief. Direct-to-consumer traction.
Why femtech startups fail
Solution seeking problem. Not addressing real pain points.
Stigma underestimation. B2B reluctance remains real.
Clinical evidence gaps. Wellness claims insufficient for scale.
How Ellty helps femtech startups
Femtech pitch decks face unique scrutiny. Clinical credibility matters most. B2B potential gets attention.
Ellty reveals:
- Market size slides: 2x longer viewing than average
- Clinical evidence: Most shared section
- Founding team diversity: Critical evaluation point
Femtech founders using Ellty report:
- Identifying truly interested investors faster
- Understanding which benefits resonate (B2B vs D2C)
- Tracking when male investors forward to female partners
FAQs
Q: B2B or D2C for femtech?
Start D2C for validation. Scale through B2B employer benefits.
Q: How important is female founder?
70% of funded femtech has female founder. Clinical advisors can balance.
Q: When to approach strategics?
After product-market fit. They want proven solutions.
Q: Regulatory considerations?
FDA pathway depends on claims. Wellness easier than medical device.
Q: International expansion timing?
Europe often more receptive. Consider early expansion.
